Children’s Symptoms with a Febrile Illness and a Positive or Negative Test of SARS-CoV-2 during the Omicron Wave
暂无分享,去创建一个
E. Jenetzky | Silke Schwarz | David D. Martin | R. Möhler | Moritz Gwiasda | Larisa Rathjens | David D Martin
[1] Yongdai Kim,et al. Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529) , 2022, BMC Medicine.
[2] E. Jenetzky,et al. Data Completeness and Concordance in the FeverApp Registry: Comparative Study , 2022, JMIR pediatrics and parenting.
[3] H. Triki,et al. SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era , 2022, Virology journal.
[4] D. Clifton,et al. Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom , 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[5] M. Peiris,et al. Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract , 2022, eBioMedicine.
[6] C. Lehmann,et al. Clinical Aspects of the Subsequent SARS-CoV-2 Waves in Children from 2020 to 2022—Data from a Local Cohort in Cologne, Germany (n = 21,635) , 2022, Viruses.
[7] G. Thouvenin,et al. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant , 2022, Frontiers in Pediatrics.
[8] W. Haas,et al. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] L. Abu-Raddad,et al. COVID-19 Disease Severity in Children Infected with the Omicron Variant , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] H. Ullum,et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study , 2022, The Lancet Infectious Diseases.
[11] A. Tagarro,et al. Features of COVID-19 in Children During the Omicron Wave Compared With Previous Waves in Madrid, Spain , 2022, The Pediatric infectious disease journal.
[12] S. Bhatt,et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.
[13] W. Schaffner,et al. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[14] A. Goga,et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study , 2022, The Lancet Child & Adolescent Health.
[15] L. Poon,et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo , 2022, Nature.
[16] G. Wei,et al. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance , 2022, J. Chem. Inf. Model..
[17] R. Mukherjee,et al. Why are some coronavirus variants more infectious? , 2021, Journal of Biosciences.
[18] M. Balaguer,et al. The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit , 2021, BMC Infectious Diseases.
[19] C. Murray,et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.
[20] T. Skoff,et al. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[21] R. Laxer,et al. Approach to recurrent fever in childhood. , 2017, Canadian family physician Medecin de famille canadien.